{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T13:35:51Z","timestamp":1793367351060,"version":"4.5.0"},"reference-count":80,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.jaad.2024.09.049","type":"journal-article","created":{"date-parts":[[2024,10,5]],"date-time":"2024-10-05T11:57:28Z","timestamp":1728129448000},"page":"1213-1224","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Hand eczema\u2014Part 2: Prevention, management, and treatment"],"prefix":"10.1016","volume":"93","author":[{"given":"Robert","family":"Bissonnette","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tove","family":"Agner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James S.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonja","family":"Molin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Guttman-Yassky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jaad.2024.09.049_bib1","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1136\/oemed-2011-100294","article-title":"Prevention of hand eczema among Danish hairdressing apprentices: an intervention study","volume":"69","author":"Bregnhoj","year":"2012","journal-title":"Occup Environ Med"},{"issue":"1","key":"10.1016\/j.jaad.2024.09.049_bib2","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/cod.12304","article-title":"Evidence-based training as primary prevention of hand eczema in a population of hospital cleaning workers","volume":"72","author":"Clemmensen","year":"2015","journal-title":"Contact Dermatitis"},{"issue":"6","key":"10.1016\/j.jaad.2024.09.049_bib3","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/cod.13502","article-title":"Health education decreases incidence of hand eczema in metal work apprentices: results of a controlled intervention study","volume":"82","author":"Reich","year":"2020","journal-title":"Contact Dermatitis"},{"issue":"3","key":"10.1016\/j.jaad.2024.09.049_bib4","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/bjd.18862","article-title":"A behaviour change package to prevent hand dermatitis in nurses working in the National Health Service: results of a cluster randomized controlled trial","volume":"183","author":"Madan","year":"2020","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2024.09.049_bib5","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/cod.13214","article-title":"Effectiveness of a skin care programme for the prevention of contact dermatitis in healthcare workers (the Healthy Hands Project): a single-centre, cluster randomized controlled trial","volume":"80","author":"Soltanipoor","year":"2019","journal-title":"Contact Dermatitis"},{"issue":"5","key":"10.1016\/j.jaad.2024.09.049_bib6","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1111\/j.0022-202X.2005.23723.x","article-title":"Fifteen-year follow-up of hand eczema: predictive factors","volume":"124","author":"Meding","year":"2005","journal-title":"J Invest Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2024.09.049_bib7","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2020-0628","article-title":"Section on dermatology SOA, immunology. Nickel allergic contact dermatitis: identification, treatment, and prevention","volume":"145","author":"Silverberg","year":"2020","journal-title":"Pediatrics"},{"issue":"4","key":"10.1016\/j.jaad.2024.09.049_bib8","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/cod.12243","article-title":"Effectiveness of the Healthy Skin Clinic-a randomized clinical trial of nurse-led patient counselling in hand eczema","volume":"71","author":"Mollerup","year":"2014","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.jaad.2024.09.049_bib9","doi-asserted-by":"crossref","DOI":"10.2340\/actadv.v104.27985","article-title":"Professional cleaners' and healthcare workers' ability to recognize hand eczema","volume":"104","author":"Glenn Ullum","year":"2024","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2024.09.049_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e7822","article-title":"Skin care education and individual counselling versus treatment as usual in healthcare workers with hand eczema: randomised clinical trial","volume":"345","author":"Ibler","year":"2012","journal-title":"BMJ"},{"issue":"4","key":"10.1016\/j.jaad.2024.09.049_bib11","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1600-0536.2011.02024.x","article-title":"The effectiveness of integrated care for patients with hand eczema: results of a randomized, controlled trial","volume":"66","author":"van Gils","year":"2012","journal-title":"Contact Dermatitis"},{"issue":"6","key":"10.1016\/j.jaad.2024.09.049_bib12","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/cod.13682","article-title":"Effectiveness of secondary prevention in metalworkers with work-related skin diseases and comparison with participants of a tertiary prevention program: a prospective cohort study","volume":"83","author":"Brans","year":"2020","journal-title":"Contact Dermatitis"},{"issue":"1","key":"10.1016\/j.jaad.2024.09.049_bib13","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/cod.13390","article-title":"Positive change in hand care habits using therapeutic patient education in chronic hand eczema","volume":"82","author":"Tauber","year":"2020","journal-title":"Contact Dermatitis"},{"issue":"2","key":"10.1016\/j.jaad.2024.09.049_bib14","first-page":"212","article-title":"Prevention of hand eczema: effect of an educational program versus treatment as usual - results of the randomized clinical PREVEX trial","volume":"44","author":"Fisker","year":"2018","journal-title":"Scand J Work Environ Health"},{"issue":"5","key":"10.1016\/j.jaad.2024.09.049_bib15","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1111\/bjd.13169","article-title":"Association between tobacco smoking and prognosis of occupational hand eczema: a prospective cohort study","volume":"171","author":"Brans","year":"2014","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2024.09.049_bib16","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1111\/bjd.17870","article-title":"Factors influencing prognosis for occupational hand eczema: new trends","volume":"181","author":"Olesen","year":"2019","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2024.09.049_bib17","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/cod.14035","article-title":"Guidelines for diagnosis, prevention, and treatment of hand eczema","volume":"86","author":"Thyssen","year":"2022","journal-title":"Contact Dermatitis"},{"issue":"4","key":"10.1016\/j.jaad.2024.09.049_bib18","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/cod.12614","article-title":"Multicentre cohort study 'rehabilitation of occupational skin diseases - optimization and quality assurance of inpatient management (ROQ)': results from a 3-year follow-up","volume":"75","author":"Brans","year":"2016","journal-title":"Contact Dermatitis"},{"issue":"9","key":"10.1016\/j.jaad.2024.09.049_bib19","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1111\/jdv.12975","article-title":"Tertiary individual prevention improves mental health in patients with severe occupational hand eczema","volume":"29","author":"Breuer","year":"2015","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.jaad.2024.09.049_bib20","doi-asserted-by":"crossref","first-page":"437","DOI":"10.5271\/sjweh.3876","article-title":"Risk of work-related hand eczema in relation to wet work exposure","volume":"46","author":"Lund","year":"2020","journal-title":"Scand J Work Environ Health"},{"issue":"4","key":"10.1016\/j.jaad.2024.09.049_bib21","article-title":"Interventions for preventing occupational irritant hand dermatitis","volume":"4","author":"Bauer","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.jaad.2024.09.049_bib22","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1111\/j.1365-2133.2009.09485.x","article-title":"Effectiveness of skin protection measures in prevention of occupational hand eczema: results of a prospective randomized controlled trial over a follow-up period of 1 year","volume":"162","author":"Kutting","year":"2010","journal-title":"Br J Dermatol"},{"issue":"Suppl 1","key":"10.1016\/j.jaad.2024.09.049_bib23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1396-0296.2004.04S1002.x","article-title":"Cleansing without compromise: the impact of cleansers on the skin barrier and the technology of mild cleansing","volume":"17","author":"Ananthapadmanabhan","year":"2004","journal-title":"Dermatol Ther"},{"issue":"8","key":"10.1016\/j.jaad.2024.09.049_bib24","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1046\/j.1365-4362.2002.01555.x","article-title":"Correlation between pH and irritant effect of cleansers marketed for dry skin","volume":"41","author":"Baranda","year":"2002","journal-title":"Int J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2024.09.049_bib25","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1111\/j.1365-2133.2005.06875.x","article-title":"Less skin irritation from alcohol-based disinfectant than from detergent used for hand disinfection","volume":"153","author":"Pedersen","year":"2005","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2024.09.049_bib26","doi-asserted-by":"crossref","first-page":"230","DOI":"10.5415\/apallergy.2014.4.4.230","article-title":"The role of antiseptic agents in atopic dermatitis","volume":"4","author":"Lee","year":"2014","journal-title":"Asia Pac Allergy"},{"issue":"3","key":"10.1016\/j.jaad.2024.09.049_bib27","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1046\/j.1523-1747.2003.12053.x","article-title":"Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities","volume":"120","author":"Kao","year":"2003","journal-title":"J Invest Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2024.09.049_bib28","article-title":"Interventions for hand eczema","volume":"4","author":"Christoffers","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"10.1016\/j.jaad.2024.09.049_bib29","first-page":"328","article-title":"A randomized, double-blind phase 4 study of the efficacy and safety of ethanol-free clobetasol propionate foam, 0.05%, vs vehicle foam in the treatment of chronic hand dermatitis","volume":"12","author":"Kircik","year":"2013","journal-title":"J Drugs Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2024.09.049_bib30","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1046\/j.1365-2133.1999.02819.x","article-title":"Long-term, intermittent treatment of chronic hand eczema with mometasone furoate","volume":"140","author":"Veien","year":"1999","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2024.09.049_bib31","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/cod.14447","article-title":"Cream versus ointment: randomized single-blinded study on the adherence to treatment with topical methylprednisolone aceponate","volume":"90","author":"Gregersen","year":"2024","journal-title":"Contact Dermatitis"},{"issue":"5","key":"10.1016\/j.jaad.2024.09.049_bib32","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1600-0536.2007.01314.x","article-title":"Tacrolimus ointment in the treatment of occupationally induced chronic hand dermatitis","volume":"58","author":"Schliemann","year":"2008","journal-title":"Contact Dermatitis"},{"issue":"2","key":"10.1016\/j.jaad.2024.09.049_bib33","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1684\/ejd.2011.1615","article-title":"Tacrolimus 0.1% vs mometasone furoate topical treatment in allergic contact hand eczema: a prospective randomized clinical study","volume":"22","author":"Katsarou","year":"2012","journal-title":"Eur J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2024.09.049_bib34","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1067\/mjd.2002.117856","article-title":"Topical tacrolimus (FK506) and mometasone furoate in treatment of dyshidrotic palmar eczema: a randomized, observer-blinded trial","volume":"46","author":"Schnopp","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2024.09.049_bib35","first-page":"426","article-title":"Efficacy of pimecrolimus 1% cream in the long term management of atopic hand dermatitis. A double-blind RCT","volume":"10","author":"Bauer","year":"2012","journal-title":"J Dtsch Dermatol Ges"},{"issue":"1","key":"10.1016\/j.jaad.2024.09.049_bib36","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000297524","article-title":"Efficacy and safety of pimecrolimus cream 1% in mild-to-moderate chronic hand dermatitis: a randomized, double-blind trial","volume":"221","author":"Hordinsky","year":"2010","journal-title":"Dermatology"},{"issue":"1","key":"10.1016\/j.jaad.2024.09.049_bib37","first-page":"31","article-title":"Pimecrolimus cream 1%: a potential new treatment for chronic hand dermatitis","volume":"73","author":"Belsito","year":"2004","journal-title":"Cutis"},{"issue":"6","key":"10.1016\/j.jaad.2024.09.049_bib38","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/j.1398-9995.2007.01406.x-i1","article-title":"Proactive treatment of atopic dermatitis in adults with 0.1% tacrolimus ointment","volume":"63","author":"Wollenberg","year":"2008","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.jaad.2024.09.049_bib39","doi-asserted-by":"crossref","first-page":"e141","DOI":"10.1097\/DER.0000000000000793","article-title":"Topical crisaborole in the treatment of atopic hand dermatitis: a retrospective chart review","volume":"32","author":"Kahn","year":"2021","journal-title":"Dermatitis"},{"issue":"5","key":"10.1016\/j.jaad.2024.09.049_bib40","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.3892\/etm.2015.2729","article-title":"Successful treatment of refractory chronic hand eczema with calcipotriol\/betamethasone ointment: a report of three cases","volume":"10","author":"Yang","year":"2015","journal-title":"Exp Ther Med"},{"issue":"7","key":"10.1016\/j.jaad.2024.09.049_bib41","first-page":"32","article-title":"Retapamulin 1% ointment and clobetasol propionate 0.05% foam is more efficacious than vehicle ointment and clobetasol 0.05% propionate foam in the treatment of hand\/foot dermatitis: a single center, randomized, double-blind study","volume":"7","author":"Haddican","year":"2014","journal-title":"J Clin Aesthet Dermatol"},{"key":"10.1016\/j.jaad.2024.09.049_bib42","doi-asserted-by":"crossref","DOI":"10.1093\/bjd\/ljad162.012","article-title":"384 Ruxolitinib 1.5% cream efficacy data for moderate-to-severe chronic hand dermatitis: open-label trial 4-weeks interim analysis","volume":"188","author":"Smith","year":"2023","journal-title":"Br J Dermatol"},{"issue":"8","key":"10.1016\/j.jaad.2024.09.049_bib44","doi-asserted-by":"crossref","first-page":"e447","DOI":"10.1111\/ijd.13205","article-title":"Use of 308 nm excimer laser for the treatment of chronic hand and foot eczema","volume":"55","author":"Shroff","year":"2016","journal-title":"Int J Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2024.09.049_bib45","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1046\/j.1365-2230.2003.01378.x","article-title":"A double-blind placebo-controlled trial of UVA-1 in the treatment of dyshidrotic eczema","volume":"28","author":"Polderman","year":"2003","journal-title":"Clin Exp Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2024.09.049_bib46","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1080\/000155598442089","article-title":"UVA1 irradiation is effective in treatment of chronic vesicular dyshidrotic hand eczema","volume":"78","author":"Schmidt","year":"1998","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"10.1016\/j.jaad.2024.09.049_bib47","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/bjd.16238","article-title":"An observer-blinded randomized controlled pilot trial comparing localized immersion psoralen-ultraviolet A with localized narrowband ultraviolet B for the treatment of palmar hand eczema","volume":"179","author":"Brass","year":"2018","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2024.09.049_bib48","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1600-0781.2007.00258.x","article-title":"Local narrowband UVB phototherapy vs. local PUVA in the treatment of chronic hand eczema","volume":"23","author":"Sezer","year":"2007","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"4","key":"10.1016\/j.jaad.2024.09.049_bib49","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/j.1365-2133.2008.08487.x","article-title":"Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trial","volume":"158","author":"Ruzicka","year":"2008","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2024.09.049_bib50","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1111\/j.1365-2133.2009.09572.x","article-title":"Successful retreatment with alitretinoin in patients with relapsed chronic hand eczema","volume":"162","author":"Bissonnette","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2024.09.049_bib51","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/j.jaad.2023.12.066","article-title":"Dupilumab treatment improves signs, symptoms, quality of life, and work productivity in patients with atopic hand and foot dermatitis: results from a phase 3, randomized, double-blind, placebo-controlled trial","volume":"90","author":"Simpson","year":"2024","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2024.09.049_bib52","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1093\/bjd\/ljad156","article-title":"Efficacy and safety of dupilumab in patients with severe chronic hand eczema with inadequate response or intolerance to alitretinoin: a randomized, double-blind, placebo-controlled phase IIb proof-of-concept study","volume":"189","author":"Voorberg","year":"2023","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2024.09.049_bib53","doi-asserted-by":"crossref","DOI":"10.1093\/bjd\/ljad162.009","article-title":"381 Improved and cleared facial and hand dermatitis with lebrikizumab in patients with moderate-to-severe atopic dermatitis","volume":"188","author":"Murase","year":"2023","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2024.09.049_bib54","article-title":"Efficacy and safety of treatment with oral alitretinoin and oral cyclosporine for chronic hand eczema: a retrospective review of 118 cases","volume":"100","author":"Jang","year":"2020","journal-title":"Acta Derm Venereol"},{"issue":"7","key":"10.1016\/j.jaad.2024.09.049_bib55","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-020192","article-title":"Study protocol: efficacy of oral alitretinoin versus oral cyclosporine A in patients with severe recurrent vesicular hand eczema (ALICsA): a randomised prospective open-label trial with blinded outcome assessment","volume":"8","author":"Oosterhaven","year":"2018","journal-title":"BMJ Open"},{"issue":"5","key":"10.1016\/j.jaad.2024.09.049_bib56","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2340\/0001555576371376","article-title":"Comparison of cyclosporine and topical betamethasone-17,21-dipropionate in the treatment of severe chronic hand eczema","volume":"76","author":"Granlund","year":"1996","journal-title":"Acta Derm Venereol"},{"issue":"4","key":"10.1016\/j.jaad.2024.09.049_bib57","doi-asserted-by":"crossref","first-page":"373","DOI":"10.3109\/09546634.2014.952608","article-title":"Open-label exploratory study of acitretin for the treatment of severe chronic hand dermatitis","volume":"26","author":"Tan","year":"2015","journal-title":"J Dermatolog Treat"},{"issue":"5","key":"10.1016\/j.jaad.2024.09.049_bib58","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/000155501317140089","article-title":"Treatment of hyperkeratotic dermatitis of the palms (eczema keratoticum) with oral acitretin. A single-blind placebo-controlled study","volume":"81","author":"Thestrup-Pedersen","year":"2001","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"10.1016\/j.jaad.2024.09.049_bib59","doi-asserted-by":"crossref","first-page":"101","DOI":"10.4103\/0378-6323.104679","article-title":"Topical clobetasol propionate 0.05% cream alone and in combination with azathioprine in patients with chronic hand eczema: an observer blinded randomized comparative trial","volume":"79","author":"Agarwal","year":"2013","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"4","key":"10.1016\/j.jaad.2024.09.049_bib60","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/cod.14161","article-title":"Efficacy and safety of oral alitretinoin versus oral azathioprine in patients with severe chronic hand eczema: results from a prematurely discontinued randomized controlled trial","volume":"87","author":"Voorberg","year":"2022","journal-title":"Contact Dermatitis"},{"issue":"8","key":"10.1016\/j.jaad.2024.09.049_bib61","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1111\/jdv.13253","article-title":"Drug survival of methotrexate treatment in hand eczema patients: results from a retrospective daily practice study","volume":"30","author":"Politiek","year":"2016","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"4","key":"10.1016\/j.jaad.2024.09.049_bib62","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/S0190-9622(99)70446-9","article-title":"Low-dose oral methotrexate treatment for recalcitrant palmoplantar pompholyx","volume":"40","author":"Egan","year":"1999","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2024.09.049_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107217","article-title":"Small molecule drug discovery targeting the JAK-STAT pathway","volume":"204","author":"Lv","year":"2024","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jaad.2024.09.049_bib64","author":"Bissonnette","year":"2022"},{"key":"10.1016\/j.jaad.2024.09.049_bib65","doi-asserted-by":"crossref","DOI":"10.2340\/actadv.v104.19454","article-title":"Real-world experience of abrocitinib treatment in patients with atopic dermatitis and hand eczema: up to 28-week results from the BioDay registry","volume":"104","author":"Kamphuis","year":"2024","journal-title":"Acta Derm Venereol"},{"issue":"5","key":"10.1016\/j.jaad.2024.09.049_bib67","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/cod.14276","article-title":"Experiences from daily practice of upadacitinib treatment on atopic dermatitis with a focus on hand eczema: results from the BioDay registry","volume":"88","author":"Kamphuis","year":"2023","journal-title":"Contact Dermatitis"},{"issue":"9","key":"10.1016\/j.jaad.2024.09.049_bib68","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.1111\/jdv.19194","article-title":"Effect of upadacitinib on atopic hand eczema in patients with moderate-to-severe atopic dermatitis: results from two randomized phase 3 trials","volume":"37","author":"Simpson","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.jaad.2024.09.049_bib71","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/bjd.21037","article-title":"The pan-JAK inhibitor delgocitinib in a cream formulation demonstrates dose response in chronic hand eczema in a 16-week randomized phase IIb trial","volume":"187","author":"Worm","year":"2022","journal-title":"Br J Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2024.09.049_bib72","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.alit.2022.06.009","article-title":"Executive summary: Japanese guidelines for atopic dermatitis (ADGL) 2021","volume":"71","author":"Saeki","year":"2022","journal-title":"Allergol Int"},{"key":"10.1016\/j.jaad.2024.09.049_bib73","unstructured":"Schliemann S, Pinter A, Schuttelaar ML et al. Efficacy and safety of delgocitinib cream in adults with moderate-to-severe chronic hand eczema: results of the Phase 3 DELTA 1 trial. European Academy of Dermatology and Venereology (EADV) Congress; October 11-15, 2023; Berlin, Germany."},{"key":"10.1016\/j.jaad.2024.09.049_bib74","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(24)01027-4","article-title":"Efficacy and safety of delgocitinib cream in adults with moderate to severe chronic hand eczema (DELTA 1 and DELTA 2): results from multicentre, randomised, controlled, double-blind, phase 3 trials","volume":"404","author":"Bissonnette","year":"2024","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jaad.2024.09.049_bib75","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jaad.2023.04.027","article-title":"Oral spleen tyrosine kinase\/Janus Kinase inhibitor gusacitinib for the treatment of chronic hand eczema: results of a randomized phase 2 study","volume":"89","author":"Jimenez","year":"2023","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2024.09.049_bib76","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1067\/mjd.2002.122757","article-title":"Hand dermatitis","volume":"47","author":"Elston","year":"2002","journal-title":"J Am Acad Dermatol"},{"issue":"4 Suppl","key":"10.1016\/j.jaad.2024.09.049_bib77","first-page":"4","article-title":"Chronic hand eczema: a prevalent and challenging skin condition","volume":"82","author":"Fowler","year":"2008","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2024.09.049_bib78","series-title":"Disability Evaluation","first-page":"413","article-title":"Dermatological impairment","author":"Taylor","year":"2003"},{"key":"10.1016\/j.jaad.2024.09.049_bib80","series-title":"Clinical Medicine for the Occupational Physician","first-page":"p299","article-title":"Occupational dermatoses","author":"Taylor","year":"1982"},{"key":"10.1016\/j.jaad.2024.09.049_bib81","author":"Knoblauch"},{"key":"10.1016\/j.jaad.2024.09.049_bib84","series-title":"Defining and Implementing Medical Standards for Workers\u2019 Compensation (Syllabus: Course on Workers\u2019 Compensation","author":"Leavitt","year":"1975"},{"key":"10.1016\/j.jaad.2024.09.049_bib85","first-page":"965","article-title":"Confusing compensation cases","volume":"3","author":"Key","year":"1967","journal-title":"Cutis"},{"issue":"5 Pt 1","key":"10.1016\/j.jaad.2024.09.049_bib86","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S0190-9622(89)70096-7","article-title":"Contact dermatitis and workers' compensation: criteria for establishing occupational causation and aggravation","volume":"20","author":"Mathias","year":"1989","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2024.09.049_bib87","series-title":"AMA Guides to the Evaluation of Permanent Impairment","author":"Rondinelli","year":"2023"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962224029530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962224029530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T00:16:35Z","timestamp":1760746595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962224029530"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":80,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0190962224029530"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2024.09.049","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hand eczema\u2014Part 2: Prevention, management, and treatment","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2024.09.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2024.09.048","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}